SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950159-12-000583
Filing Date
2012-10-25
Accepted
2012-10-25 16:51:05
Documents
1
Group Members
QUAKER BIOVENTURES CAPITAL II L.P.QUAKER BIOVENTURES CAPITAL II LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D quakerbio13da.htm SC 13D/A 83809
  Complete submission text file 0000950159-12-000583.txt   85541
Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428 484-567-0130
NUPATHE INC. (Subject) CIK: 0001375200 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85616 | Film No.: 121162059
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A